Tofacitinib Versus Methotrexate in Treating Mucocutaneous and Musculoskeletal Lesions of Systemic Lupus Erythematosus: Real‐World Results From the CSTAR Cohort XXXII
Sign Up to like & getrecommendations! Published in 2025 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.70283
Abstract: This study aimed to evaluate and compare the efficacy and safety of tofacitinib versus methotrexate in the management of systemic lupus erythematosus (SLE) within a real‐world cohort, with a particular focus on mucocutaneous and musculoskeletal… read more here.
Keywords: tofacitinib versus; real world; systemic lupus; mucocutaneous musculoskeletal ... See more keywords
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2021-0311
Abstract: Aim: To compare rates of biologic initiation after commencing treatment with apremilast (APR) versus methotrexate (MTX) in systemic-naive patients with psoriasis (PsO). Methods: This was a retrospective cohort study of systemic-naive patients with PsO who… read more here.
Keywords: versus methotrexate; apremilast; biologic initiation; systemic naive ... See more keywords